- Filed
- Dec 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Dec 2, 2025 | 44.49M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2025 | 44.74M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2025 | 44.33M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2024 | 44.94M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2024 | 45.4M sh |
| Stock Repurchased | Q2 2026 · Oct 31, 2025 | $0 |
| Stock Repurchased | Q2 2026 · Oct 31, 2024 | $22.62M |
| Dividends Paid | Q2 2026 · Oct 31, 2025 | $11.66M |
| Dividends Paid | Q2 2026 · Oct 31, 2024 | $11.65M |
| Capex | Q2 2026 · Oct 31, 2025 | $15.28M |
| Capex | Q2 2026 · Oct 31, 2024 | $8M |
| Operating Cash Flow | Q2 2026 · Oct 31, 2025 | $19.16M |
| Operating Cash Flow | Q2 2026 · Oct 31, 2024 | −$38.21M |
| Cash And Equivalents | Q2 2026 · Oct 31, 2025 | $22.43M |
| Cash And Equivalents | Q2 2026 · Apr 30, 2025 | $25.23M |
| Stockholders Equity | Q2 2026 · Oct 31, 2025 | $363.2M |
| Stockholders Equity | Q2 2026 · Jul 31, 2025 | $364.38M |
| Stockholders Equity | Q2 2026 · Apr 30, 2025 | $372.45M |
| Stockholders Equity restated | Q2 2026 · Oct 31, 2024 | $371.48M |
| Stockholders Equity restated | Q2 2026 · Jul 31, 2024 | $379.99M |
| Stockholders Equity restated | Q2 2026 · Apr 30, 2024 | $399.91M |
| Current Liabilities | Q2 2026 · Oct 31, 2025 | $53.89M |
| Current Liabilities | Q2 2026 · Apr 30, 2025 | $66.64M |
| Total Liabilities | Q2 2026 · Oct 31, 2025 | $185.39M |
| Total Liabilities | Q2 2026 · Apr 30, 2025 | $187.16M |
| Current Assets | Q2 2026 · Oct 31, 2025 | $268.52M |
| Current Assets | Q2 2026 · Apr 30, 2025 | $277.27M |
| Total Assets | Q2 2026 · Oct 31, 2025 | $548.58M |
| Total Assets | Q2 2026 · Apr 30, 2025 | $559.61M |
| Eps Diluted | Q2 2026 · Oct 31, 2025 | $0.04 |
| Eps Diluted | Q2 2026 · Oct 31, 2025 | −$0.03 |
| Eps Diluted restated | Q2 2026 · Oct 31, 2024 | $0.10 |
| Eps Diluted restated | Q2 2026 · Oct 31, 2024 | $0.06 |
| Eps Basic | Q2 2026 · Oct 31, 2025 | $0.04 |
| Eps Basic | Q2 2026 · Oct 31, 2025 | −$0.03 |
| Eps Basic restated | Q2 2026 · Oct 31, 2024 | $0.10 |
| Eps Basic restated | Q2 2026 · Oct 31, 2024 | $0.06 |
| Sga Expense | Q2 2026 · Oct 31, 2025 | $13.47M |
| Sga Expense | Q2 2026 · Oct 31, 2025 | $26.78M |
| Sga Expense restated | Q2 2026 · Oct 31, 2024 | $15.21M |
| Sga Expense restated | Q2 2026 · Oct 31, 2024 | $28.58M |
| Rd Expense | Q2 2026 · Oct 31, 2025 | $2.43M |
| Rd Expense | Q2 2026 · Oct 31, 2025 | $5.44M |
| Rd Expense | Q2 2026 · Oct 31, 2024 | $2.22M |
| Rd Expense | Q2 2026 · Oct 31, 2024 | $4.74M |
| Net Income | Q2 2026 · Oct 31, 2025 | $1.92M |
| Net Income | Q2 2026 · Oct 31, 2025 | −$1.49M |
| Net Income restated | Q2 2026 · Oct 31, 2024 | $4.55M |
| Net Income restated | Q2 2026 · Oct 31, 2024 | $2.69M |
| Operating Income | Q2 2026 · Oct 31, 2025 | $4.12M |
| Operating Income | Q2 2026 · Oct 31, 2025 | $1.16M |
| Operating Income restated | Q2 2026 · Oct 31, 2024 | $7.54M |
| Operating Income restated | Q2 2026 · Oct 31, 2024 | $6.01M |
| Gross Profit | Q2 2026 · Oct 31, 2025 | $30.35M |
| Gross Profit | Q2 2026 · Oct 31, 2025 | $52.42M |
| Gross Profit restated | Q2 2026 · Oct 31, 2024 | $34.5M |
| Gross Profit restated | Q2 2026 · Oct 31, 2024 | $58.69M |
| Cost Of Revenue | Q2 2026 · Oct 31, 2025 | $94.32M |
| Cost Of Revenue | Q2 2026 · Oct 31, 2025 | $157.32M |
| Cost Of Revenue restated | Q2 2026 · Oct 31, 2024 | $95.18M |
| Cost Of Revenue restated | Q2 2026 · Oct 31, 2024 | $159.32M |
| Revenue | Q2 2026 · Oct 31, 2025 | $124.67M |
| Revenue | Q2 2026 · Oct 31, 2025 | $209.75M |
| Revenue | Q2 2026 · Oct 31, 2024 | $129.68M |
| Revenue | Q2 2026 · Oct 31, 2024 | $218.01M |